This is the authors' abstract. We don't add key points for this paper.
These results indicate that cystatin F mediates NK cell suppression in GBM. Targeting its activation enhances NK cell cytotoxicity, offering a potential strategy to improve NK-based immunotherapy for glioblastoma.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Senjor et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: